B12014—Surgery/Division of Urology

Contact:

Mentor:  Sunil Sudarshan, MD, University of Alabama at Birmingham, Department of Surgery, Division of Urology

Current email: This email address is being protected from spambots. You need JavaScript enabled to view it.

The Department of Surgery-Urology is accepting positions for  post-doctoral fellows in the field of urologic oncology with an emphasis on renal and prostate cancers.  The position will begin in July.  We are seeking highly motivated candidates who will conduct basic research with a translational emphasis.  Our laboratory interests include the metabolism of cancer cells.   In particular, our laboratory is interested in the metabolic changes present in cancer cells and the mechanisms by which these changes occur.  We are also interested in the role of putative oncometabolites- small molecules with potential transforming properties.  Additionally, our laboratory is interested in mTOR signaling with an emphasis on the mTORC signaling complex 2 (mTORC2).   Finally, our laboratory is also interested in the epigenetics of renal cancer as many histone modifying genes have recently been identified as mutated in renal cancer.  Through gene complementation studies, we are interested in the role of chromatin biology in the pathogenesis of renal cancer. 

Expertise with basic techniques utilizing DNA, RNA, protein, and tissue culture is required.  Candidates need to demonstrate independence and the ability to communicate. 

Ph.D. and/or M.D. degree is required. Applicants please send curriculum vitae with a description of research interests and names of three references with email addresses to: Sunil Sudarshan, M.D. email:  This email address is being protected from spambots. You need JavaScript enabled to view it.

UAB News

  • A new study involving researchers from the University of Alabama at Birmingham and other institutions says patients with Type 1 and Type 2 diabetes should eat a diet low in carbohydrates.

  • The University of Alabama at Birmingham has enrolled the first patient in the United States in a Phase III clinical trial to find a treatment for preeclampsia. Preeclampsia affects a relatively small number of pregnancies – 5 to 8 percent – but its prevalence is growing.

UAB Research News

  • Shirey, who will be inducted in September, is nationally recognized for her innovative integration of teaching and learning strategies.Maria R. Shirey, Ph.D., professor and assistant dean for Clinical Affairs and Partnerships in the University of Alabama at Birmingham School of Nursing, has been selected for induction as a fellow into the National League for Nursing Academy of Nursing Education. Shirey is nationally recognized for her innovative integration of teaching and learning strategies using research, evidence-based practice...

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...